Yoel Lubell holds a PhD in Health Economics from the London School of Hygiene & Tropical Medicine (LSHTM) and is a Professor of Global Health at the University of Oxford. He leads the Economics and Implementation Research Group at the Mahidol-Oxford Tropical Medicine Research Unit (MORU), where he oversees a multidisciplinary team of health economists, clinical researchers, and implementation scientists. His research focuses on the cost-effectiveness of diagnostics, treatments, and vaccines for malaria and other infectious diseases, with a particular emphasis on developing and evaluating diagnostic and prognostic tools to improve the management of febrile illnesses in resource-limited settings.

As the Principal Investigator of the South and Southeast Asian Community-Based Trials Network (SEACTN), he leads a large-scale initiative conducting community-based observational studies and clinical trials across South and Southeast Asia. The network is dedicated to assessing the effectiveness, scalability, and cost-efficiency of healthcare interventions in rural and underserved populations. SEACTN has executed the largest observational studies into the causes of febrile illness in the region and implemented intervention trials aimed at improving their management. By embedding research directly within these communities, SEACTN ensures that its findings are locally relevant, facilitating integration into public health policies. This work aims to bridge the gap between health policy, clinical practice, and economic constraints, with the ultimate goal of improving healthcare outcomes for vulnerable populations in resource-limited settings.